NDRA | tickerfilter.com

Fundamental analysis

23%

Profitability 25%

Dept financing 23%

Liquidity 47%

Performance 15%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

-4.36%

1 Month

-8.29%

3 Months

2,509.94%

6 Months

5,309.70%

1 Year

200.88%

2 Year

-0.64%

Key data

Stock price

$5.50

P/E Ratio

0.00

DAY RANGE

$5.33 - $5.37

EPS

$0.00

52 WEEK RANGE

$0.04 - $8.80

52 WEEK CHANGE

$166.45

MARKET CAP

27.723 M

YIELD

N/A

SHARES OUTSTANDING

72.440 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

N/A

BETA

0.00

PUBLIC FLOAT

AVERAGE 10 VOLUME

$48,759

AVERAGE 30 VOLUME

$75,697

Company detail

CEO: Francois Michelon
Region: US
Website: endrainc.com
Employees: 20
IPO year: -

Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

ENDRA Life Sciences Inc. develops thermo-acoustic enhanced ultrasound technology. Technology transmits sound waves, which bounce off tissues, organs, and blood in the body. Thermoablative surgery, vascular imaging, and tissue perfusion technologies also offer diagnostic imaging technologies.

NDRA - ENDRA Life Sciences Inc.